Related Experiment Video
Updated: Apr 5, 2026
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Stromal Cell-Derived Factor-1α Plays a Crucial Role Based on Neuroprotective Role in Neonatal Brain Injury in Rats
Miki Mori1, Keiichi Matsubara2, Yuko Matsubara3
1Department of Obstetrics and Gynecology, Ehime University School of Medicine, Toon, Ehime 791-0295, Japan. morimiki@m.ehime-u.ac.jp.
Insights
Stromal cell-derived factor-1α (SDF-1α) improved cognitive deficits in neonatal rats with hypoxic-ischemic brain damage. SDF-1α reduced inflammation and promoted remyelination, but did not improve motor coordination.
Area of Science:
- Neuroscience
- Neonatal Medicine
- Regenerative Medicine
Background:
- Increased survival of preterm infants has led to a rise in cerebral palsy incidence.
- Cerebral palsy is often caused by neonatal hypoxic-ischemia (HI), a condition lacking effective treatments.
- Neonatal brain damage from HI significantly impacts long-term neurological function.
Purpose of the Study:
- To investigate the therapeutic potential of stromal cell-derived factor-1α (SDF-1α) in a rat model of neonatal hypoxic-ischemia (HI).
- To evaluate the effects of SDF-1α on cognitive functions, motor coordination, and neuropathological changes following neonatal HI.
- To determine if SDF-1α can mitigate brain damage and improve neurological outcomes in affected neonates.
Main Methods:
- A rat model of neonatal hypoxic-ischemia (HI) was established by ligating the left common carotid artery and exposing seven-day-old Wistar rat pups to hypoxia.
- Animals received SDF-1α treatment post-HI to assess its impact on neurological deficits.
- Behavioral tests (e.g., memory, spatial perception, motor coordination) and immunohistochemistry were employed to evaluate treatment efficacy and underlying mechanisms.
Main Results:
- SDF-1α treatment significantly improved memory and spatial perception abilities in HI rats.
- Motor coordination deficits resulting from HI were not ameliorated by SDF-1α treatment.
- Immunohistochemistry revealed that SDF-1α reduced intracranial inflammation and promoted cerebral remyelination post-HI.
Conclusions:
- SDF-1α demonstrates a specific therapeutic benefit for cognitive impairments, particularly spatial perception, in neonatal hypoxic-ischemic encephalopathy.
- The neuroprotective effects of SDF-1α appear to be mediated by reduced inflammation and enhanced remyelination.
- Further research into SDF-1α may offer novel treatment strategies for specific neurological deficits associated with neonatal brain injury.
Abstract:
Owing to progress in perinatal medicine, the survival of preterm newborns has markedly increased. However, the incidence of cerebral palsy has risen in association with increased preterm birth. Cerebral palsy is largely caused by cerebral hypoxic ischemia (HI), for which there are no effective medical treatments. We evaluated the effects of stromal cell-derived factor-1α (SDF-1α) on neonatal brain damage in rats. Left common carotid (LCC) arteries of seven-day-old Wistar rat pups were ligated, and animals were exposed to hypoxic gas to cause cerebral HI. Behavioral tests revealed that the memory and spatial perception abilities were disturbed in HI animals, and that SDF-1α treatment improved these cognitive functions. Motor coordination was also impaired after HI but was unimproved by SDF-1α treatment. SDF-1α reduced intracranial inflammation and induced cerebral remyelination, as indicated by the immunohistochemistry results. These data suggest that SDF-1α specifically influences spatial perception abilities in neonatal HI encephalopathy.
More Related Videos
11:57Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
Published on: February 23, 2015
09:56Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury
Published on: July 27, 2014